Tesser, John http://orcid.org/0000-0002-2706-7171
Gül, Ahmet http://orcid.org/0000-0001-8219-3720
Olech, Ewa http://orcid.org/0000-0001-7386-0894
Oelke, Kurt
Lukic, Tatjana
Kwok, Kenneth http://orcid.org/0000-0002-7475-3369
Ebrahim, Abbas http://orcid.org/0000-0002-8100-9677
Article History
Received: 23 March 2023
Accepted: 27 August 2023
First Online: 2 November 2023
Declarations
:
: Each trial was conducted in accordance with the Declaration of Helsinki and International Council for Harmonisation Guidelines for Good Clinical Practice and approved by the institutional review board and/or independent ethics committee for each study center. All patients provided written informed consent.
: Not applicable.
: JT has received grant/research support from AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Genentech, Gilead, Janssen, and Pfizer Inc, has been a consultant/advisory board member for AbbVie, Bristol Myers Squibb, Eli Lilly, Janssen, Pfizer Inc, and Sanofi-Genzyme, and is a member of the speakers’ bureau for AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Janssen, Pfizer Inc, and Sanofi-Genzyme. AG has been a consultant for AbbVie, Bristol Myers Squibb, MSD, Novartis, Pfizer Inc, Roche, Servier, UCB, and Xoma. EO has received grant/research support from, and has been a consultant for, AbbVie, Amgen, Celgene, Genentech, Janssen, Pfizer Inc, Regeneron, Sanofi Aventis, UCB, and Vertex Pharmaceuticals. KO has been a member of the speakers’ bureau for AbbVie, Amgen, Bristol Myers Squibb, Crescendo Biosciences, GSK, Pfizer Inc, and UCB. TL, KK, and AE are employees and shareholders of Pfizer Inc.